LISA GATWOOD: Open Payments
NPI 1881846681 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 84 payments from 15 companies in 2025. Trend: 2023 $1,779 · 2024 $1,803 · 2025 $1,348
Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $310 |
| Novo Nordisk Inc | 12 | $194 |
| Axsome Therapeutics, Inc. | 7 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $111 |
| Lilly USA, LLC | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Tris Pharma Inc | 4 | $75 |
| PFIZER INC. | 3 | $69 |
| Amgen Inc. | 4 | $61 |
| Corium, LLC | 3 | $56 |
Products named: VRAYLAR, Auvelity, XIFAXAN, JARDIANCE, Wegovy, QULIPTA, UBRELVY, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
